Literature DB >> 30170837

Prevalence and sociodemographic disparities of Hepatitis C in Baby Boomers and the US adult population.

Kevin J Moore1, Aliyah Gauri1, Tulay Koru-Sengul2.   

Abstract

BACKGROUND: The US Baby Boomer (BB) generation is associated with high rates of Hepatitis C virus (HCV) infection. There is limited literature detailing age-specific risk factors for HCV infection. Using a nationally representative sample, this study examines US adult HCV prevalence and age-specific risk factors for chronic HCV infection.
METHODS: We analyzed data from National Health and Nutrition Examination Survey (NHANES) for years 1999-2012. Age was divided into three categories: BB, younger than BB (YG) and older than BB (OG). HCV status was determined by the presence of a positive HCV antibody and a positive HCV RNA. Sociodemographic variables were analyzed by HCV status. Multivariable logistic regression models adjusting for sociodemographic variables were fitted to identify age-specific risk factors for HCV positivity.
RESULTS: The overall prevalence of chronic HCV was 1.19% with a US population estimate of 2,347,852 US adults. BB had the highest prevalence at 2.23%, accounting for over 74% of all chronic HCV cases. HCV prevalence was highest among all ages (1.83%) and BB (2.71%) in 2001-2002 survey cycle. Among BB, males, non-Hispanic blacks, positive blood transfusion history, current and former smoker, and living below the poverty line were significant predictors of chronic HCV positivity.
CONCLUSION: This study highlights the elevated prevalence of chronic HCV among BB and identifies age-specific risk factors for chronic HCV infection. As the BB population ages, it is important to use these generation-specific risk factors that can guide health professionals in targeted screening and public health prevention efforts.
Copyright © 2018 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Age-specific risk factors; Baby Boomers; Hepatitis C; NHANES; Prevention

Mesh:

Substances:

Year:  2018        PMID: 30170837     DOI: 10.1016/j.jiph.2018.08.003

Source DB:  PubMed          Journal:  J Infect Public Health        ISSN: 1876-0341            Impact factor:   3.718


  9 in total

Review 1.  The changing landscape of cancer in the USA - opportunities for advancing prevention and treatment.

Authors:  Farhad Islami; Rebecca L Siegel; Ahmedin Jemal
Journal:  Nat Rev Clin Oncol       Date:  2020-05-28       Impact factor: 66.675

2.  Hepatitis B, C, and D Virus Infections and AFP Tumor Marker Prevalence Among the Elderly Population in Mongolia: A Nationwide Survey.

Authors:  Davaalkham Dambadarjaa; Yerkyebulan Mukhtar; Enkh-Oyun Tsogzolbaatar; Ser-Od Khuyag; Angarmurun Dayan; Nandin-Erdene Oyunbileg; Oyu-Erdene Shagdarsuren; Gunchmaa Nyam; Yosikazu Nakamura; Masaharu Takahashi; Hiroaki Okamoto
Journal:  J Prev Med Public Health       Date:  2022-05-20

3.  Factors and HCV treatment outcomes associated with smoking among people who inject drugs on opioid agonist treatment: secondary analysis of the PREVAIL randomized clinical trial.

Authors:  Irene Pericot-Valverde; Moonseong Heo; Matthew J Akiyama; Brianna L Norton; Linda Agyemang; Jiajing Niu; Alain H Litwin
Journal:  BMC Infect Dis       Date:  2020-12-04       Impact factor: 3.090

4.  High hepatitis C virus seropositivity, viremia, and associated risk factors among trans women living in San Francisco, California.

Authors:  Christopher J Hernandez; Dillon Trujillo; Sofia Sicro; Joaquin Meza; Mackie Bella; Emperatriz Daza; Francisco Torres; Willi McFarland; Caitlin M Turner; Erin C Wilson
Journal:  PLoS One       Date:  2021-03-30       Impact factor: 3.240

5.  Epidemiology of Hepatitis C virus infection among incarcerated populations in North Dakota.

Authors:  Liton Chandra Deb; Hannah Hove; Tracy K Miller; Kodi Pinks; Grace Njau; John J Hagan; Rick J Jansen
Journal:  PLoS One       Date:  2022-03-29       Impact factor: 3.240

6.  Sustained Impact of the Coronavirus Disease 2019 Pandemic on Hepatitis C Virus Treatment Initiations in the United States.

Authors:  Martin Hoenigl; Daniela Abramovitz; Ricardo E Flores Ortega; Natasha K Martin; Nancy Reau
Journal:  Clin Infect Dis       Date:  2022-08-24       Impact factor: 20.999

Review 7.  Hepatitis C Virus Structure: Defined by What It Is Not.

Authors:  Altaira D Dearborn; Joseph Marcotrigiano
Journal:  Cold Spring Harb Perspect Med       Date:  2020-01-02       Impact factor: 6.915

Review 8.  Expanding the donor pool: Hepatitis C, hepatitis B and human immunodeficiency virus-positive donors in liver transplantation.

Authors:  James F Crismale; Jawad Ahmad
Journal:  World J Gastroenterol       Date:  2019-12-21       Impact factor: 5.742

9.  Evaluation of a strategy for identification of hepatitis C virus carriers in outpatient and emergency units: contribution to the microelimination of hepatitis C in Brazil.

Authors:  Rodrigo Gardona; Flavia Appel; Samara Ercolin; Roberto J Carvalho-Filho; Dulce A Barbosa; Maria Lucia Ferraz
Journal:  Braz J Infect Dis       Date:  2021-02-23       Impact factor: 3.257

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.